Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Innovex International (INVX) EBT (2016 - 2025)

Innovex International (INVX) has disclosed EBT for 17 consecutive years, with $27.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, EBT rose 103.97% year-over-year to $27.0 million, compared with a TTM value of $128.5 million through Dec 2025, up 122.79%, and an annual FY2025 reading of $128.5 million, up 122.79% over the prior year.
  • EBT was $27.0 million for Q4 2025 at Innovex International, down from $58.0 million in the prior quarter.
  • Across five years, EBT topped out at $80.0 million in Q3 2024 and bottomed at -$679.3 million in Q4 2024.
  • Average EBT over 5 years is -$27.5 million, with a median of $5.8 million recorded in 2023.
  • The sharpest move saw EBT skyrocketed 313.39% in 2022, then crashed 1912.15% in 2024.
  • Year by year, EBT stood at -$72.1 million in 2021, then skyrocketed by 104.42% to $3.2 million in 2022, then plummeted by 1158.91% to -$33.8 million in 2023, then plummeted by 1912.15% to -$679.3 million in 2024, then surged by 103.97% to $27.0 million in 2025.
  • Business Quant data shows EBT for INVX at $27.0 million in Q4 2025, $58.0 million in Q3 2025, and $22.2 million in Q2 2025.